This test measures levels of CA 19-9 in the blood and it is most often used to monitor cancers of the pancreas or bile ducts. Because levels of CA 19-9 are also raised with other cancers and some benign conditions the test is not specific enough to be used for diagnosis.  

Once a diagnosis is established CA 19-9 has an important role to play in monitoring cancer treatment and to watch for recurrence. Repeated measurements are often used during and following treatment because rising or falling levels can give your doctor information about whether your treatment is successful.

CA 19-9 is a protein that is found on the surface of certain cells in the pancreas and other internal organs. Healthy people have low levels of CA 19-9 in their blood.  However, pancreatic cancer cells produce high levels of CA 19-9 making it useful as a tumour marker to follow the course of pancreatic cancer.

CA 19-9 is high in most people with advanced pancreatic cancer but it can also be raised in other cancers including bowel, stomach, colorectal, lung, thyroid, cancers as well as other non-malignant conditions such as gallstones, pancreatitis, cystic fibrosis and liver disease.  Because many other conditions can cause CA 19-9 to rise it is not recommended as a screening test for people who do not have symptoms of pancreatic cancer.

At present there is no single laboratory test that can diagnose early pancreatic cancer. Your doctor will consider your signs and symptoms and may order CA 19-9 along with Carcinoembryonic Antigen (CEA) and Liver Function Tests (LFTs).

If you are being treated for pancreatic cancer your doctor may order a CA 19-9 test on a regular basis to monitor whether your treatment is effective. Repeated measurements of CA 19-9 are often carried out during and following treatment because rising or falling levels can give your doctor important information about whether the treatment is working and whether all of the cancer was removed successfully during surgery. It can also provide a warning if the cancer is returning.

Your doctor may also order a CT scan (computed tomography), an ultrasound, an ERCP (endoscopic retrograde cholangiopancreatography, a procedure in which a small lighted tube is passed through the mouth and stomach into the small intestine), and/or a biopsy to look for cancer cells under the microscope. 

Samples of the cancer may be tested for abnormalities (mutations) of the gene K-RAS to help the doctor decide on the best treatment.

Sample

Blood

Any preparation?

None

Reading your test report

Your results will be presented along with those of your other tests on the same form.  You will see separate columns or lines for each of these tests.

Low amounts of CA 19-9 can be detected in some healthy people and many conditions that affect the liver or pancreas can cause a temporary rise in CA 19-9.

Moderate to high levels are found in pancreatic cancer, other cancers, and some benign conditions. The highest levels of CA 19-9 are seen in pancreatic ductal adenocarcinoma – a cancer that is found in the pancreas tissues that produce food-digesting enzymes and in the ducts that carry those enzymes into the small intestine. This is where the vast majority of pancreatic cancers are found.

Not everyone with pancreatic cancer will develop high levels of CA 19-9. Five to ten percent of people with a Caucasian background have a particular blood type described as Lewis negative and these people test negative for CA 19-9 even if they have pancreatic cancer.

If you are being treated for pancreatic cancer you may be tested several times throughout your treatment. As a tumour shrinks CA 19-9 levels can be expected to go down.  If a cancer returns or spreads, levels are expected to rise. 
 

Reference intervals

Your results will be compared to reference intervals (sometimes called a normal range).

• Reference intervals are the range of results expected in healthy people. 
• When compared against them your results may be flagged high or low if they sit outside this range.
• Many reference intervals vary between labs so only those that are standardised or harmonised across most laboratories are given on this website.

If your results are flagged as high or low this does not necessarily mean that anything is wrong. It depends on your personal situation. Your results need to be interpreted by your doctor.

The choice of tests your doctor makes will be based on your medical history and symptoms.   It is important that you tell them everything you think might help.

You play a central role in making sure your test results are accurate. Do everything you can to make sure the information you provide is correct and follow instructions closely.

Talk to your doctor about any medications you are taking. Find out if you need to fast or stop any particular foods or supplements. These may affect your results. Ask:

• Why does this test need to be done?
• Do I need to prepare (such as fast or avoid medications) for the sample collection?
• Will an abnormal result mean I need further tests?
• How could it change the course of my care?
• What will happen next, after the test?

It is still unclear what causes most cases of pancreatic cancer. Identified risk factors include smoking, age (most are over 50 years old), gender (males are more likely to have it than females), family history, diabetes, obesity, chronic pancreatitis, and heavy occupational exposure to certain chemicals and dyes.

Pathology and diagnostic imaging reports can be added to your My Health Record. You and your healthcare provider can now access your results whenever and wherever needed.

Get further trustworthy health information and advice from healthdirect.